The American Thoracic Society has released a new clinical practice guideline on the pharmacologic management of chronic obstructive pulmonary disease. The American Thoracic Society (ATS) has released ...

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is a chronic disease that affects quality of life and mobility, and can lead to respiratory ...

Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...

Background: Chronic obstructive pulmonary disease (COPD) is a prevalent disease that is frequently treated in primary care. However, data regarding the primary care management of COPD are scarce. Such ...

We therefore conducted a study to compare the regular pharmacological treatment of stable COPD patients in clinical practice with the previous (2010) and current (2011) GOLD guidelines and to ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

Applying guidelines is a universal challenge that is often not met. Intelligent software systems that facilitate real-time management during a clinical interaction may offer a solution. We have ...

Investigators explored common challenges cited by hospital staff as barriers to implementation and adherence with national guidelines for managing chronic obstructive pulmonary disease (COPD). In a ...

—More than 90% of patients with advanced COPD experience dyspnea. A daily morphine dose of <30 mg daily is safe for treating refractory breathlessness. Reviewed by Rima R. Gidwani, MD, Assistant ...

I was recently diagnosed with COPD, but I still smoke. Is it too late to quit since my lungs are already damaged? It’s not too late! Even if you have smoked for many years, you can still benefit from ...

Based on low certainty evidence from 4 trials, the ATS panel made a conditional recommendation against the use of maintenance oral corticosteroids in patients with COPD and a history of severe and ...